A Short Course in Biologics is a CPD initiative developed by Professor Stephen Mahler. An increasing proportion of pharmaceutical company revenue is derived from biologics, with growth in new biologics exceeding that of pharmaceuticals.
Course participants include stakeholders from the biologics industry, including those working in regulatory affairs, pharmaceutical companies, biotechnology small and medium enterprises, patent and legal services, research institutes, clinical medicine and other organisations. Courses can be delivered on-demand, as face-to-face seminars or workshops, or online.